From bark to weed: The history of artemisinin

Parasite

C. Faurant¹ 

[1] Consultant, East West Pharmaceuticals, 189, rue Grande,77300 Fontainebleau,France

关键词: history;    artemisinin combined therapy;    ACT;    artemisinin;    523 project;    malaria;    sweet woodworm;   

Others  :  808854
DOI  :  doi:10.1051/parasite/2011183215

 received in 2011-05-13, accepted in 2011-05-16,  发布年份 2011

【 摘 要 】

In the 1970’s, in China, some brilliant and courageous scientists carried out a research programme, which lead to the discovery of artemisinin derivatives and new quinoleines that are used today, in combination, as first line treatment of malaria.

【 授权许可】

   
© PRINCEPS Editions, Paris, 2011

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Anonymous . (History of Qinghaosu and Prof. Zhou Keding). Beijing, CIP, 2008, 329 p.
• [2]The Global Fund. AMFm (Affordable Medicines Facility – malaria), accessed 12/05/2011 (www.theglobalfund.org/fr/amfm/history).
• [3]Arnold K. Quinghaosu and derivatives in the treatment of malaria. A personal review. J Hong Kong Med Assoc,1993, 45, 189–196.
• [4]Ashley L. DHA investigator’s brochure, data on file. Holley- Cotec, 2004.
• [5]Bougnoux M.E., Ancelle T. Place de l’artéméther parmi les dérivés du qinghaosu. Cahiers Santé, 1993, 3, 308–313.
• [6]Burns W.R. East meets West: how China almost cured malaria. Endeavour,2008, 32, 101–106. [PubMed]
• [7]Centre For Novel Agricultural Products (CNAP). Artemisia research project, accessed 12/05/2011 (www.york.ac.uk/org/cnap/artemisiaproject/index.htm).
• [8]Danis M., Chandenier J., Doumbo O., Kombila M., Kouame J., Louis P., Roche G. & Gentilini M. Results obtained with I.M. artemether versus quinine in the treatment of severe malaria in multicentre study in Africa. Am J Trop Med Hyg, 1996, 24, 93–96.
• [9]Gardner B.A. A present from Chairman Mao, in: Wellcome News Supplement 6: Research Directions in Malaria. The Wellcome Trust 2002, p. 25.
• [10]Hien T.T. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Trans R Soc Trop Med Hyg, 1994, 88(Suppl. 1), S7–S8. [PubMed]
• [11]Hien T.T., Day N.P.J., Phu N.H., Mai N.T.H., Chau T.T.H., Loc P.P., Sinh D.X., Chuong L.V., Vinh H., Waller D., Peto T.E.A. & White N.J. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Eng J Med,1996, 335, 76–83.
• [12]Li G.Q., Guo X.B., Fu L.C., Jian H.X. & Wang X.H. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg, 1994, 88(Suppl. 1), 5–6.
• [13]Li Y. & Wu Y.L. An over four millennium story behind qinghaosu (artemisinin) – a fantastic antimalarial drug from a traditional chinese herb. Curr Med Chem, 2003, 10, 2197–2230. [PubMed]
• [14]Medicines For Malaria Venture (MMV) Research programme, accessed 12/05/2011 (www.mmv.org/research-development/project-portfolio/oz-439).
• [15]QHS Research Group. Crystal structure and absolute configuration of qinghaosu. Sciencia Sinica, 1980, 23, 380–396.
• [16]White N.J., Nosten F., Looareesuwan S., Watkins W.M., Marsh K., Snow R.W., Kokwaro G., Ouma J., Hien T.T., Molyneux M.E., Taylor T.E., Newbold C.I., Ruebush T.K.2nd,Danis M., Greenwood B.M., Anderson R.M. & Olliaro P. Averting a malaria disaster. Lancet, 1999, 353, 1965–1967. [PubMed]
• [17]World Health Organization (WHO). Prequalification programme, accessed 12/05/2011 (http://www.who.int/topics/prequalification/en).